Wound Care Technologies: Sales Growth, Change, Global Forecast

MedMarket Diligence is hours away from publishing its 2015 report on the worldwide wound management market.

The report is entitled, “Worldwide Wound Management, Forecast to 2024: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World”. The report is described in detail at link.

The very diverse field that is wound management encompasses technologies from gauze to bioengineered skin and skin substitutes and many in between. Growth rates range from flat to over 15% annually through 2024.

Source: MedMarket Diligence, LLC; Report #S251.

The highest growth segments in medical technology sectors typically derive their high growth from modest absolute changes on very small volume and therefore rarely can sustain that growth over time. However, in wound management, the use of bioengineered skin and skin substitutes will result in the highest cumulative sales compared to all segments from 2015 to 2024 — excluding, that is, the high volume segments of traditional adhesives, gauzes, and non-adherent dressings.  Also noteworthy is the second highest cumulative sales over this period was for antimicrobial dressings, despite this segment having relatively modest growth on a percentage basis, but proceeding from significant sales in 2015 (already at over $1.5 billion).

Source: MedMarket Diligence, LLC; Report #S251.

During the forecast period, the most significant change evident in sales is the jump in the share of the market represented by bioengineered and other skin replacements, as noted above. But with compound annual growth rates (to 2024) in sales in the different wound segments ranging from near 1% to nearly 20% — for segments with 2015 sales at a low of $300 million and a high of $15 billion — there is considerable shifting of shares of the global wound market.

Source: MedMarket Diligence, LLC; Report #S251.

On a geographic basis, wound care technology migration, efforts to secure underserved patient caseload, and other forces result in growth rates that vary by country or region. The well-developed USA market therefore does not compare in uptake of both old and new technologies within growth markets like China and others in the Asia/Pacific region.

Source: MedMarket Diligence, LLC; Report #S251.

Medical technologies at startups, July 2014

Below is a list of technologies under development at medical technology startups identified in July 2014 and included in the Medtech Startups Database.

  • thrombectomyInstrumentation for electrophysiology diagnosis and treatment.
  • Products for the treatment of hypertension and other chronic disease by interventional cardiologists
  • Surgical stapling device for use during natural orifice transluminal endoscopic surgery.
  • Low cost medical technologies to improve patient management in emerging markets.
  • Heart valve for the treatment of mitral valve regurgitation
  • Thrombectomy catheter
  • Microstaple bandage for wound closure.
  • Whole-body cryotherapy chambers as well as devices for local cryotherapy and cryosurgery.
  • Minimally invasive surgical device for the treatment of glaucoma
  • Electrical muscle stimulation.

For a historical listing of medical technologies at startups, see link.

Obesity by Country

The global obesity market is steadily growing as a result of increased prevalence and recognition by governments and industry of the severity of the problem.  However, the severity of the problem (and the associated opportunity to provide solutions) varies considerably from country to country.  While western democracies and their well developed consumer markets and standards of living allow consumption to excess, less well developed markets demonstrate considerably less utilization yet, in some cases (such as China), show considerably greater potential as their economies rapidly grow and become more "western-like".

Below is illustrated, for select countries, the total clinical obesity treatment market per country in the aggregate and as a per capita value. 

Source: MedMarket Diligence, LLC: Report #S835, "Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019."

Spine surgery is an exception to the usual country market rules

A great many markets for medical technologies have similar market drivers, economics, regulatory restraints and other features, resulting frequently in market sizes that can be fairly accurately predicted on the basis of population.  Hence, U.S. markets are often a consistent size relative to European markets. 

Spine surgery device markets are a decided exception to this rule.

Source: MedMarket Diligence, LLC; Report #M520.

 

Numerous facets of the underlying market size determinants for America and Europe for spine surgery devices are just plain different.  Reimbursement levels are different (and changing), regulatory policies have trended in different directions at varying paces, clinical practice patterns are influenced by local variables — the result is surprising variability in the relative market size of spine surgery device markets in the Americas and the European Union.

(This is only a consideration of the Americas and Europe.  Individual European countries also vary from the European aggregate. Further, spine surgery device markets in China, Japan, India, Australia and other countries have their own unique drivers.)


Global markets for spine surgery devices are the subject of the July 2011 MedMarket Diligence, LLC, Report #M520.  

The MedMarket Diligence report #M520, "Worldwide Spine Surgery: Products, Technologies, Markets & Opportunities, 2010-2020", is a detailed market and technology assessment and forecast of the products and technologies in the management of diseases and disorders of the spine as outlined in the following preliminary table of contents. The report describes the diseases and disorders of the spine, characterizing the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. This report details the currently available products and technologies, and the manufacturers offering them. The report details the products and technologies under development and markets for each in spine surgery. The report provides a current and ten-year forecast by region/country of procedures, unit sales, average selling price and manufacturer revenues for, specifically, Americas (USA, Canada, Mexico, Brazil), European Union (United Kingdom, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (Japan, China, India, Australia/New Zealand) and Rest of World. The forecasts address product- and country-specific impacts in the market of new technologies through the coming decade. The report profiles 46 key companies in this industry, providing data on their current products, current market position and products under development.